Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | IM / LA |
Patient developed a widespread rash soon after Shingrix injection (most recent injection at the end of Februrary). She never had a similar rash in the past and has no history of lichenoid dermatitis. She was treated with topical triamcinolone cream. While her rash has completely resolved, she now has significant post-inflammatory skin changes. Of note, patient developed an unexplained pulmonary embolism in May of 2025. While we cannot say with certainty that this was secondary to Shingrix injection and while I did not see her for her embolism (she went to the emergency room for this), she had no other pre-disposing factors and no other explainable etiology for her embolism. She now takes Xarelto.
None
None
N/A
NKDA
A punch biopsy was conducted with the following results: LICHENOID DERMATITIS, SEE COMMENT COMMENT: In the context of the clinical impression, the histopathologic findings could be compatible with a vaccine induced lichenoid eruption.